We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





Technopath Presents Comprehensive Portfolio of Diagnostic Quality Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: IAMQC Transfer is the company’s latest connectivity solution (Photo courtesy of Technopath)
Image: IAMQC Transfer is the company’s latest connectivity solution (Photo courtesy of Technopath)

Technopath Clinical Diagnostics (Tipperary, Ireland) will be exhibiting at the annual AACC in Chicago, IL, July 25-28 as part of the LGC Clinical Diagnostics Group which represents the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. Technopath will present a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials at AACC 2022.

Technopath is showcasing the Multichem range of barcoded consolidated Quality Control (QC) materials combined with IAMQC informatics software that offer unique work-flow automation. By utilizing Multichem barcoded QC materials, laboratories can optimize their QC workflow and minimize handling errors. The company’s newest barcoded QC products can be recognized by the instrument, QC targets automatically downloaded to the instrument, and QC data automatically collected and reported in real-time. Technopath is also highlighting its Multichem range of independent consolidated QC materials. With an extensive list of analytes included in the Multichem range of quality control products, choice and flexibility are guaranteed for all customers. The company’s third-party quality control products include general clinical chemistry, immunoproteins, immunoassay, cardiac, urine chemistry, infectious disease, diabetes and other esoteric controls.

In addition, Technopath will demonstrate the IAMQC Infinity open QC data management solution that can complement and support the Multichem QC product range, and provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Infinity is practical, graphical, user-definable and easy to use and provides laboratories with a centralized standardized approach to QC data management. Technopath’s IAMQC range of software products includes IAMQC Peer, an innovative, real-time, peer comparison software; IAMQC Transfer, a connectivity device (available as a virtual or physical device) that can communicate with Laboratory Information Systems (LIS), middleware, and to automated instrumentation and point of care platforms; and IAMQC Proficiency testing, a cloud-based portal used for automated submission of PT data and full PT scheme management for PT providers.
 

Related Links:
Technopath Clinical Diagnostics 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.